BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Allergy to pollen
,
Endothelial cell
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
human methyl- cpg binding domain protein 2
Summary
General Info
Curated Studies
Most Correlated Studies
UHRF1 protein depletion by shRNA treatment in HCT116 cells
Prostate adenocarcinoma LNCaP cells expressing MBD2 shRNA
Mammary epithelial HMEC cells, genetically transformed and treated with 5-aza-dC or depleted of MBD2
Myeloma MM.1S cells with PHF19 shRNA knockdown rescued
Embryonic kidney HEK293T cells overexpressing full length or truncated alternate isoform of TET1
Explore Curated Studies Results
Literature
Most Relevant Literature
iTRAQ-based chromatin proteomic screen reveals CHD4-dependent recruitment of MBD2 to sites of DNA da…
An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma.
Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis.
Genetic association study between methyl-CpG-binding domain genes and schizophrenia among Chinese fa…
Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spect…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ccf mtDNA as a Neurodegenerative Biomarker
Family Resilience Initiative Research Program
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ